![Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working](https://ars.els-cdn.com/content/image/1-s2.0-S1044579X17302171-gr3.jpg)
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working
![Frontiers | Scoring System for Tumor-Infiltrating Lymphocytes and Its Prognostic Value for Gastric Cancer Frontiers | Scoring System for Tumor-Infiltrating Lymphocytes and Its Prognostic Value for Gastric Cancer](https://www.frontiersin.org/files/Articles/418697/fimmu-10-00071-HTML/image_m/fimmu-10-00071-g001.jpg)
Frontiers | Scoring System for Tumor-Infiltrating Lymphocytes and Its Prognostic Value for Gastric Cancer
![Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers | Diagnostic Pathology | Full Text Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers | Diagnostic Pathology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13000-018-0743-7/MediaObjects/13000_2018_743_Fig1_HTML.png)
Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers | Diagnostic Pathology | Full Text
![Composite analysis of immunological and metabolic markers defines novel subtypes of triple negative breast cancer | Modern Pathology Composite analysis of immunological and metabolic markers defines novel subtypes of triple negative breast cancer | Modern Pathology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fmodpathol.2017.126/MediaObjects/41379_2018_Article_BFmodpathol2017126_Fig1_HTML.jpg)
Composite analysis of immunological and metabolic markers defines novel subtypes of triple negative breast cancer | Modern Pathology
The prognostic significance of tumor-infiltrating lymphocytes assessment with hematoxylin and eosin sections in resected primary lung adenocarcinoma | PLOS ONE
![Cancers | Free Full-Text | Spatial Characterization of Tumor-Infiltrating Lymphocytes and Breast Cancer Progression | HTML Cancers | Free Full-Text | Spatial Characterization of Tumor-Infiltrating Lymphocytes and Breast Cancer Progression | HTML](https://www.mdpi.com/cancers/cancers-14-02148/article_deploy/html/images/cancers-14-02148-g001.png)
Cancers | Free Full-Text | Spatial Characterization of Tumor-Infiltrating Lymphocytes and Breast Cancer Progression | HTML
![Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast | Modern Pathology Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast | Modern Pathology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41379-018-0040-8/MediaObjects/41379_2018_40_Fig1_HTML.jpg)
Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast | Modern Pathology
![Clinical significance of tumor-infiltrating lymphocytes in breast cancer | Journal for ImmunoTherapy of Cancer Clinical significance of tumor-infiltrating lymphocytes in breast cancer | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/4/1/59/F1.large.jpg)
Clinical significance of tumor-infiltrating lymphocytes in breast cancer | Journal for ImmunoTherapy of Cancer
![Utilizing Automated Breast Cancer Detection to Identify Spatial Distributions of Tumor-Infiltrating Lymphocytes in Invasive Breast Cancer - The American Journal of Pathology Utilizing Automated Breast Cancer Detection to Identify Spatial Distributions of Tumor-Infiltrating Lymphocytes in Invasive Breast Cancer - The American Journal of Pathology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5fda8f5f-8ad7-489b-8e75-2b98f94a216c/gr1_lrg.jpg)
Utilizing Automated Breast Cancer Detection to Identify Spatial Distributions of Tumor-Infiltrating Lymphocytes in Invasive Breast Cancer - The American Journal of Pathology
![Figure 3 from The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. | Semantic Scholar Figure 3 from The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f6341a130a85f0b905968be6878150709dfb5a5e/9-Figure3-1.png)
Figure 3 from The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. | Semantic Scholar
![Why pathologists and oncologists should know about tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer: an Australian experience of 139 cases - Pathology Why pathologists and oncologists should know about tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer: an Australian experience of 139 cases - Pathology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/bb84f45a-80cb-4f77-aaa7-1bef69d546a6/gr1_lrg.jpg)
Why pathologists and oncologists should know about tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer: an Australian experience of 139 cases - Pathology
![Clinical relevance of host immunity in breast cancer: from TILs to the clinic | Nature Reviews Clinical Oncology Clinical relevance of host immunity in breast cancer: from TILs to the clinic | Nature Reviews Clinical Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrclinonc.2015.215/MediaObjects/41571_2016_Article_BFnrclinonc2015215_Fig1_HTML.jpg)
Clinical relevance of host immunity in breast cancer: from TILs to the clinic | Nature Reviews Clinical Oncology
![Cancers | Free Full-Text | The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance | HTML Cancers | Free Full-Text | The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance | HTML](https://www.mdpi.com/cancers/cancers-13-06012/article_deploy/html/images/cancers-13-06012-g001.png)
Cancers | Free Full-Text | The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance | HTML
![Predictive Relevance of Tumor-infiltrating Lymphocytes in Breast Cancer | Asian Archives of Pathology Predictive Relevance of Tumor-infiltrating Lymphocytes in Breast Cancer | Asian Archives of Pathology](https://www.asianarchpath.com/storage/media_articles/51_files/51-1.jpg)
Predictive Relevance of Tumor-infiltrating Lymphocytes in Breast Cancer | Asian Archives of Pathology
![Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group | npj Breast Cancer Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-020-0154-2/MediaObjects/41523_2020_154_Fig1_HTML.png)
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group | npj Breast Cancer
![The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition - Annals of Oncology The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b5046b60-4b5f-4e1e-808c-78f1c1cafcaf/gr1.jpg)
The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition - Annals of Oncology
![Frontiers | Assessing Tumor-Infiltrating Lymphocytes in Breast Cancer: A Proposal for Combining Immunohistochemistry and Gene Expression Analysis to Refine Scoring Frontiers | Assessing Tumor-Infiltrating Lymphocytes in Breast Cancer: A Proposal for Combining Immunohistochemistry and Gene Expression Analysis to Refine Scoring](https://www.frontiersin.org/files/Articles/794175/fimmu-13-794175-HTML-r1/image_m/fimmu-13-794175-g001.jpg)
Frontiers | Assessing Tumor-Infiltrating Lymphocytes in Breast Cancer: A Proposal for Combining Immunohistochemistry and Gene Expression Analysis to Refine Scoring
![The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 - ScienceDirect The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419313699-gr2.jpg)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 - ScienceDirect
![Frontiers | Clinical Validity and Utility of Tumor-Infiltrating Lymphocytes in Routine Clinical Practice for Breast Cancer Patients: Current and Future Directions Frontiers | Clinical Validity and Utility of Tumor-Infiltrating Lymphocytes in Routine Clinical Practice for Breast Cancer Patients: Current and Future Directions](https://www.frontiersin.org/files/Articles/284538/fonc-07-00156-HTML/image_m/fonc-07-00156-g002.jpg)
Frontiers | Clinical Validity and Utility of Tumor-Infiltrating Lymphocytes in Routine Clinical Practice for Breast Cancer Patients: Current and Future Directions
![Relationship Between the Neutrophil to Lymphocyte Ratio, Stromal Tumor-infiltrating Lymphocytes, and the Prognosis and Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer - Clinical Breast Cancer Relationship Between the Neutrophil to Lymphocyte Ratio, Stromal Tumor-infiltrating Lymphocytes, and the Prognosis and Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer - Clinical Breast Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e5753e1a-9476-454b-b84a-8f86e32cb61a/gr1_lrg.jpg)
Relationship Between the Neutrophil to Lymphocyte Ratio, Stromal Tumor-infiltrating Lymphocytes, and the Prognosis and Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer - Clinical Breast Cancer
![Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I–III patients treated with standard therapy - European Journal of Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I–III patients treated with standard therapy - European Journal of](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ea0c509c-c32c-466b-994b-0eb974a4854a/gr1_lrg.jpg)
Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I–III patients treated with standard therapy - European Journal of
![MuTILs: explainable, multiresolution computational scoring of Tumor-Infiltrating Lymphocytes in breast carcinomas using clinical guidelines | medRxiv MuTILs: explainable, multiresolution computational scoring of Tumor-Infiltrating Lymphocytes in breast carcinomas using clinical guidelines | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2022/01/13/2022.01.08.22268814/F1.large.jpg)